Selective activation of quisqualate metabotropic receptor potentiates NMDA but not AMPA responses.
Aniksztejn
L
L
INSERM U29, Hôpital de Port-Royal, Paris, France.
Bregestovski
P
P
Ben-Ari
Y
Y
D000818:Animals; D003515:Cycloleucine / Q000031:analogs & derivatives / Q000494:pharmacology; D006624:Hippocampus / Q000033:anatomy & histology / Q000502:physiology / Q000648:ultrastructure; D007051:Ibotenic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects / Q000502:physiology*; D016202:N-Methylaspartate / Q000494:pharmacology* / Q000502:physiology; D009474:Neurons / Q000502:physiology / Q000648:ultrastructure; D018091:Receptors, AMPA; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology*; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
D007473:Ion Channels; D018091:Receptors, AMPA; D017981:Receptors, Neurotransmitter; D003515:Cycloleucine; C036361:1-amino-1,3-dicarboxycyclopentane; D007051:Ibotenic Acid; D016202:N-Methylaspartate; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid